JP Drafts (September 2025)

JP drafts for public comments (September 1, 2025 to November 30, 2025)

New monographs

• Gliclazide Tablets[165KB] (001-2509eng.pdf)

 

The guidance to send comments on the JP drafts is as follows:

1. Download the form for comments in Word format[67.0KB]
2. Fill in the form
3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
4. Send it to the email address: JPdraft-eng[at]pmda.go.jp

Note:
For the purpose of security, this email address is partly incorrect. Please replace [at] with @ when sending an email.

Related Information

• Columns (Chemical drug)

 

Note:
The information submitted with the comments may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).
Your comments will be considered for the preparation of JP final drafts, but no individual response will be made to each comment.